Gene therapy may offer release from sterile isolation for patients lacking immune systems Part 4

We've removed all the common verbs from this article, try and put them back correctly.

Gene therapy may offer release from sterile isolation for patients lacking immune systems Part 4 (Teacher: Michael)

Because the ADA enzyme is , for a variety of metabolic processes in the body, a more complex disease than other SCIDs. In previous studies, Bordignon , researchers to continue giving patients enzyme replacement therapy for the metabolic problems, when gene therapy the immune component of the disorder under control.

The two patients in the Science study never received enzyme replacement therapy, which is not an option for them in their home countries. Bordignon's observed the build-up of minimal toxic metabolites, indicating that the gene therapy controlling the metabolic of the disorder as .

Eventually, Bordignon plans to try using the gene therapy method for treating other diseases, including AIDS.

This study follows earlier research by Marina Cavazzana-Calvo and colleagues, published in April 28, 2000, issue of Science. The French research team blood stem cells in gene therapy to treat two infants with SCID XI, a variation of the disease caused by a mutation on the X chromosome.

Read the article